Latest filing published 24 Oct 2023 for MEI Pharma, Inc., €797k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Funicular Funds, LP discloses dealings in 2 companies, chiefly Lite Strategy, Inc. and Oruka Therapeutics, Inc. In total, 6 filings cover trades dated from 1 July 2022 to 20 October 2023.
On the market, this insider has only ever bought: 2 purchases, €657k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants. 2023 to date brings 2 purchases and no sales.
The newest entry dates from 24 October 2023: a share grant of €797k, in Lite Strategy, Inc. The latest purchase dates back some time: it was published 1,119 days ago, on 25 September 2023. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations